In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Eledon Pharmaceuticals Inc (NASDAQ: ELDN) closed the day trading at $2.71 down -1.09% from the previous closing price of $2.74. In other words, the price has decreased by -$1.09 from its previous closing price. On the day, 0.76 million shares were traded. ELDN stock price reached its highest trading level at $2.815 during the session, while it also had its lowest trading level at $2.67.
Ratios:
For a better understanding of ELDN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.91 and its Current Ratio is at 13.91. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On January 28, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELDN now has a Market Capitalization of 162579088 and an Enterprise Value of 38578020.
Stock Price History:
The Beta on a monthly basis for ELDN is -0.09, which has changed by 0.020676732 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, ELDN has reached a high of $5.54, while it has fallen to a 52-week low of $2.38. The 50-Day Moving Average of the stock is -14.15%, while the 200-Day Moving Average is calculated to be -26.82%.
Shares Statistics:
Over the past 3-months, ELDN traded about 621.63K shares per day on average, while over the past 10 days, ELDN traded about 1425880 shares per day. A total of 59.88M shares are outstanding, with a floating share count of 55.34M. Insiders hold about 7.58% of the company’s shares, while institutions hold 61.59% stake in the company. Shares short for ELDN as of 1752537600 were 3105017 with a Short Ratio of 4.99, compared to 1749772800 on 1329307. Therefore, it implies a Short% of Shares Outstanding of 3105017 and a Short% of Float of 5.8000002.
Earnings Estimates
Its stock is currently analyzed by 6.0 different market analysts. The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.16 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$0.49 and -$1.02 for the fiscal current year, implying an average EPS of -$0.82. EPS for the following year is -$1.0, with 4.0 analysts recommending between -$0.72 and -$1.2.
